Close menu

July 31st, 2023 | 09:20 CEST

Bayer, Defense Metals, Alibaba - Stocks with doubling potential

  • Mining
  • Tungsten
  • RareEarths
  • Pharma
Photo credits:

Discovering stocks with high growth potential during difficult market periods is a challenging task. While there is no guarantee that a stock will double in value, certain factors can help identify companies with promising growth prospects. One effective approach is to focus on industries that offer growth opportunities even in adverse market conditions. Otherwise, examining fundamentals and ensuring the story fits the current spirit of the times is advisable. We have selected three possible doubling candidates.

time to read: 4 minutes | Author: Armin Schulz

Table of contents:

    Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG
    "[...] China's dominance is one of the reasons why we are so heavily involved in the tungsten market. Here, around 85% of production is in Chinese hands. [...]" Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG

    Full interview


    Bayer - A doubling candidate?

    Bayer lowered its fiscal year outlook on July 24. Instead of EUR 51 billion to EUR 52 billion, the Group is only targeting between EUR 48.5 billion and EUR 49.5 billion. The Company also lowered EBITDA from the planned EUR 12.5 billion to EUR 13 billion to EUR 11.3 billion to EUR 11.8 billion. Free cash flow was adjusted from EUR 3 billion to around EUR 0. The exact figures for Q2 will not be announced until August 8, but it has already been reported that it expects sales of around EUR 11 billion and EBITDA of EUR 2.5 billion. The main reason is the poor sales figures, especially for glyphosate products.

    However, if you look at the Company from a long-term perspective, Bayer is well-positioned. At the Crop Science Innovation Summit, the Company presented a strategy to tap into adjacent markets of conventional agriculture. This would increase market potential from EUR 100 billion to EUR 200 billion. Since new CEO Bill Anderson took the helm, rumors of a spin-off of the Crop Science division have also emerged. This would significantly raise the value of the Pharmaceuticals division, where some experts see individual products with as much potential as the current market capitalization of the entire Group.

    A new research strategy is also being pursued in the pharmaceuticals sector to bring innovations to market more quickly. In the next few years, the legal disputes surrounding glyphosate in the US should also end, and this would finally remove the constant sword of Damocles hanging over the Group. The share reacted surprisingly positively to the forecast reduction and exited Xetra trading on Friday at EUR 52.40. The majority of analysts also responded positively and, despite the bad news, issued 6 buy recommendations with price targets between EUR 65 and EUR 92. Only 2 analysts advised to hold.

    Defense Metals - Independence from China

    Since the outbreak of the Ukraine conflict, many Western countries have become aware that they should not become overly dependent on individual partners. A critical raw material to which this applies is rare earths, which are indispensable for the production of many key technologies. The wide range of applications is creating growing demand. If China were to restrict its exports, it would have significant implications for the world. The Canadian company Defense Metals is actively working on the Wicheeda rare earths project in British Columbia to reduce this dependency. The deposit covers 4,244 hectares and has a high concentration of rare earths, making it very promising.

    The preliminary economic assessment indicated an after-tax net present value of USD 397 million and an after-tax internal rate of return of 18%. The pilot plant has already been completed. The required hydrometallurgical Phase II pilot plant tests were successfully completed on June 6. More than 90% of praseodymium (Pr) and neodymium (Nd) were recovered from the acidic baked calcine. With the rare earths recovered from the facility, Defense Metals has the opportunity to provide samples to potential customers and establish business relationships. At the same time, the Company has begun preparing a prefeasibility study (PFS), which is expected to be completed in H1 2024.

    Once completed, Defense Metals could cover about 10% of global production and be able to supply about 25,000 tons of rare earth oxides (REO) per year. This would be a significant 1st step towards independence from China, especially since the Company pays close attention to ESG standards. The stock came under pressure with the last private placement, in which the Company raised CAD 12.5 million and is currently trading at CAD 0.23. This gives the Company a market capitalization of CAD 58.8 million, which compares favorably to many of its peers. Long-term investors could add a potential doubler to their portfolio with this promising project.

    Alibaba - Will the spin-offs bring the breakthrough?

    At Alibaba, the upswing of the tech giants has passed by. This is mainly due to regulatory risks related to tensions between the US and China. However, there are increasing signs that the tide could turn. The Chinese group has made a change in its top management. The transition to Eddie Wu and the restructuring plans, such as the spin-off of individual businesses to reduce the conglomerate discount, should benefit shareholders.

    The Company is currently exploring options for combining its video businesses, including streaming platforms and a possible IPO. They could potentially come back into consideration for Ant Group as well. The CYN 7.12 billion fine imposed by China's central bank could signal the end of a protracted regulatory dispute. These restructurings are expected to boost growth and strengthen the group in various areas, such as cloud computing and logistics.

    It is also doing a lot of other things for shareholders. Last quarter, Alibaba reported strong growth in several business categories and a significant increase in profitability due to cost-cutting initiatives. The Company generated significant free cash flow and engaged in share repurchases. Last Friday, the stock broke the psychologically important USD 100 barrier on the New York Stock Exchange, closing at USD 100.55. If the hurdle at USD 105.05 is cleared, prices of over USD 120 are quickly possible. As a result of the potential spin-offs, shareholders could soon see even higher profits.

    In order to find stocks that have the potential to double, one needs to consider a longer time horizon. Current negative news can weaken a share price in the short term, but as long as the long-term forecasts are positive, you can accumulate the stocks. Bayer is going through a difficult phase but seems well equipped with new strategiesfor the future. A spin-off of Crop Science would boost the stock significantly. Defense Metals offers an opportunity with its rare earths to reduce dependence on China. The critical raw material is becoming increasingly important for new technologies. Alibaba is doing a lot for its shareholders, and without the geopolitical tensions and the Chinese government, the stock would already be much higher today. China is growing, and so will Alibaba.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Armin Schulz

    Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

    About the author

    Related comments:

    Commented by André Will-Laudien on September 22nd, 2023 | 07:20 CEST

    Recalculation! These are the bare figures: TUI, Saturn Oil + Gas, Deutsche Bank - Buy prices non-stop!

    • Mining
    • Oil
    • travel
    • Investments
    • Banking

    Companies do not always have good figures in their baggage. Analysts listen very carefully to the words of those in charge. Often, it is only a minor sentence that changes entire valuations. TUI is slowly approaching pre-COVID figures. Saturn Oil & Gas must backtrack slightly because of substantial forest fires in Alberta, and Deutsche Bank aims to finalize the Postbank project in 2023. All three stocks offer good buying opportunities because the long-term prospects are quite convincing.


    Commented by Juliane Zielonka on September 22nd, 2023 | 06:50 CEST

    Cardiol Therapeutics, BioNTech, BYD - At top speed to new markets

    • Biotechnology
    • Pharma
    • Electromobility

    Cardiol Therapeutics is enjoying a remarkable development. The biotech company is now rolling out its ARCHER patient recruitment trial internationally at 35 participating centers. This accelerates research in the development of their therapy to combat myocarditis, a heart inflammation which has been associated with COVID-19 vaccination. For Cardiol Therapeutics, this represents an opportunity to get its therapy approved as an orphan drug. Approval is also at stake for BioNTech. With a multimillion-dollar funding boost, the Company is working on accelerated approval for a vaccine against a virus that caused quite a stir last year. The shortened development time is likely to impress investors. While business nations agree on fighting viruses, they disagree on commodities for the road. The EU would prefer to restrict BYD's successful sales on domestic roads - by imposing tariffs. BYD, meanwhile, is tapping into a completely different market.


    Commented by Nico Popp on September 21st, 2023 | 07:00 CEST

    Turnaround cancelled? Where 100% is possible: Varta, BYD, Manuka Resources

    • Mining
    • Vanadium
    • PreciousMetals
    • Batteries
    • Electromobility

    When soccer players move to a better team, it usually comes with higher earnings. Sometimes, the training is more intense, and the tasks off the pitch are more extensive. It is no longer comparable to the idyllic life at their former club. Athletes are then faced with the question, "Give up or bite the bullet?" The situation is similar for battery pioneer Varta, which is implementing its e-car plans with Porsche, of all companies. The sports car manufacturer offers major growth opportunities but is also considered meticulous among engineers. We highlight Varta's stock, take a look at BYD and outline opportunities at a company many have never heard of!